{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:36:56Z","timestamp":1788413816384,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570795"],"award-info":[{"award-number":["81570795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-026-06661-2","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:36:15Z","timestamp":1769106975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLP-2 alleviates postmenopausal osteoporosis by acting on osteoblasts through the PI3K\/AKT\/FOXO1 signalling pathway to downregulate FGF23 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"Kefen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing\u2019er","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"issue":"10","key":"6661_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/gerona\/glt093","volume":"68","author":"JA Cauley","year":"2013","unstructured":"Cauley JA. Public health impact of osteoporosis. J Gerontol Biol Sci Med Sci. 2013;68(10):1243\u201351.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"9319","key":"6661_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359(9319):1761\u20137.","journal-title":"Lancet"},{"issue":"1","key":"6661_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7326\/M19-0533","volume":"171","author":"HA Fink","year":"2019","unstructured":"Fink HA, MacDonald R, Forte ML, et al. Long-Term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann Intern Med. 2019;171(1):37\u201350.","journal-title":"Ann Intern Med"},{"issue":"3","key":"6661_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res. 2007;22(3):465\u201375.","journal-title":"J Bone Min Res"},{"issue":"1","key":"6661_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12891-021-03960-z","volume":"22","author":"JP Brown","year":"2021","unstructured":"Brown JP, Adachi JD, Schemitsch E, et al. Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario. BMC Musculoskelet Disord. 2021;22(1):105.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"6661_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s001980170017","volume":"12","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Loannidis G, Berger C, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12(11):903\u20138.","journal-title":"Osteoporos Int"},{"issue":"1","key":"6661_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, et al. Pharmacological management of postmenopausal osteoporosis: a level I evidence based-expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"6661_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, et al. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.","journal-title":"J Orthop Surg Res"},{"issue":"4","key":"6661_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1159\/000527502","volume":"69","author":"YM Huang","year":"2023","unstructured":"Huang YM, Xu B, Kuai Z, et al. Glucagon-like peptide-2 ameliorates age-associated bone loss and gut barrier dysfunction in senescence-accelerated mouse prone 6 mice. Gerontology. 2023;69(4):428\u201349.","journal-title":"Gerontology"},{"key":"6661_CR10","doi-asserted-by":"publisher","first-page":"106058","DOI":"10.1016\/j.phrs.2022.106058","volume":"176","author":"MBN Gabe","year":"2022","unstructured":"Gabe MBN, Skov-Jeppesen K, Gasbjerg LS, et al. GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. Pharmacol Res. 2022;176:106058.","journal-title":"Pharmacol Res"},{"key":"6661_CR11","doi-asserted-by":"publisher","first-page":"100251","DOI":"10.1016\/j.bonr.2020.100251","volume":"12","author":"B Gobron","year":"2020","unstructured":"Gobron B, Bouvard B, Legrand E, et al. GLP-2 administration in ovariectomized mice enhances collagen maturity but did not improve bone strength. Bone Rep. 2020;12:100251.","journal-title":"Bone Rep"},{"issue":"3","key":"6661_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","volume":"40","author":"DB Henriksen","year":"2007","unstructured":"Henriksen DB, Alexandersen P, Hartmann B, et al. Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. Bone. 2007;40(3):723\u20139.","journal-title":"Bone"},{"issue":"5","key":"6661_CR13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","volume":"35","author":"M Mirams","year":"2004","unstructured":"Mirams M, Robinson BG, Mason RS, et al. Bone as a source of FGF23: regulation by phosphate? Bone. 2004;35(5):1192\u20139.","journal-title":"Bone"},{"issue":"6","key":"6661_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.bone.2007.01.017","volume":"40","author":"Y Yoshiko","year":"2007","unstructured":"Yoshiko Y, Wang H, Minamizaki T, et al. Mineralized tissue cells are a principal source of FGF23. Bone. 2007;40(6):1565\u201373.","journal-title":"Bone"},{"issue":"2","key":"6661_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11154-015-9318-z","volume":"16","author":"JE Blau","year":"2015","unstructured":"Blau JE, Collins MT. The PTH-Vitamin D-FGF23 axis. Rev Endocr Metab Disord. 2015;16(2):165\u201374.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"6661_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1515\/hmbci-2015-0068","volume":"28","author":"M Kawai","year":"2016","unstructured":"Kawai M. The FGF23\/Klotho axis in the regulation of mineral and metabolic homeostasis. Horm Mol Biol Clin Investig. 2016;28(1):55\u201367.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"6661_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jbmr.2606","volume":"31","author":"SK Murali","year":"2016","unstructured":"Murali SK, Roschger P, Zeitz U, et al. FGF23 regulates bone mineralization in a 1,25(OH)2 D3 and klotho-independent manner. J Bone Miner Res. 2016;31(1):129\u201342.","journal-title":"J Bone Min Res"},{"issue":"5","key":"6661_CR18","first-page":"497","volume":"104","author":"E Celik","year":"2013","unstructured":"Celik E, Guzel S, Abali R, et al. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women. Minerva Med. 2013;104(5):497\u2013504.","journal-title":"Minerva Med"},{"issue":"5","key":"6661_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/ijms23052500","volume":"23","author":"W Sirikul","year":"2022","unstructured":"Sirikul W, Siri-Angkul N, Chattipakorn N, et al. Fibroblast growth factor 23 and osteoporosis: evidence from bench to bedside. Int J Mol Sci. 2022;23(5):2500.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6661_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cmet.2013.06.014","volume":"18","author":"X Shi","year":"2013","unstructured":"Shi X, Zhou F, Li X, et al. Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons. Cell Metab. 2013;18(1):86\u201398.","journal-title":"Cell Metab"},{"issue":"6","key":"6661_CR21","doi-asserted-by":"publisher","first-page":"R585","DOI":"10.1152\/ajpregu.00096.2014","volume":"307","author":"X Guan","year":"2014","unstructured":"Guan X. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. Am J Physiol Regul Integr Comp Physiol. 2014;307(6):R585\u2013596.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"6661_CR22","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/jbmr.4308","volume":"36","author":"K Skov-Jeppesen","year":"2021","unstructured":"Skov-Jeppesen K, Hepp N, Oeke J, et al. The antiresorptive effect of GIP, but not GLP-2, is preserved in patients with hypoparathyroidism-A randomized crossover study. J Bone Miner Res. 2021;36(8):1448\u201358.","journal-title":"J Bone Min Res"},{"issue":"8","key":"6661_CR23","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1111\/jcmm.16384","volume":"25","author":"W Luo","year":"2021","unstructured":"Luo W, Jiang Y, Yi Z, et al. 1\u0251,25-dihydroxyvitamin D(3) promotes osteogenesis by down-regulating FGF23 in diabetic mice. J Cell Mol Med. 2021;25(8):4148\u201356.","journal-title":"J Cell Mol Med"},{"issue":"22","key":"6661_CR24","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.1800160115","volume":"115","author":"L Bar","year":"2018","unstructured":"Bar L, Feger M, Fajol A, et al. Insulin suppresses the production of fibroblast growth factor 23 (FGF23). Proc Natl Acad Sci USA. 2018;115(22):5804\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6661_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3177\/jnsv.69.220","volume":"69","author":"X Liu","year":"2023","unstructured":"Liu X, He C, Koyama T. D-Pinitol ameliorated osteoporosis via elevating D-chiro-inositol level in ovariectomized mice. J Nutr Sci Vitaminol. 2023;69(3):220\u20138.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"1","key":"6661_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, et al. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6661_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, et al. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318.","journal-title":"J Orthop Surg Res"},{"issue":"15","key":"6661_CR28","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.3390\/ijms22158299","volume":"22","author":"HJ Ihn","year":"2021","unstructured":"Ihn HJ, Lim J, Kim K, et al. Protective effect of ciclopirox against ovariectomy-induced bone loss in mice by suppressing osteoclast formation and function. Int J Mol Sci. 2021;22(15):8299.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6661_CR29","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.3390\/nu13082570","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang N, Li L, et al. Menaquinone 4 reduces bone loss in ovariectomized mice through dual regulation of bone remodeling. Nutrients. 2021;13(8):2570.","journal-title":"Nutrients"},{"key":"6661_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lfs.2019.04.013","volume":"226","author":"B Xu","year":"2019","unstructured":"Xu B, He Y, Lu Y, et al. Glucagon like peptide 2 has a positive impact on osteoporosis in ovariectomized rats. Life Sci. 2019;226:47\u201356.","journal-title":"Life Sci"},{"issue":"5","key":"6661_CR31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","volume":"45","author":"DB Henriksen","year":"2009","unstructured":"Henriksen DB, Alexandersen P, Hartmann B, et al. Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD. Bone. 2009;45(5):833\u201342.","journal-title":"Bone"},{"issue":"4","key":"6661_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/003655202317316006","volume":"37","author":"KV Haderslev","year":"2002","unstructured":"Haderslev KV, Jeppesen PB, Hartmann B, et al. Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol. 2002;37(4):392\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"6661_CR33","doi-asserted-by":"publisher","first-page":"721506","DOI":"10.3389\/fendo.2021.721506","volume":"12","author":"A Mieczkowska","year":"2021","unstructured":"Mieczkowska A, Bouvard B, Legrand E, et al. [Gly(2)]-GLP-2, but not glucagon or [D-Ala(2)]-GLP-1, controls collagen crosslinking in murine osteoblast cultures. Front Endocrinol. 2021;12:721506.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10 Suppl","key":"6661_CR34","first-page":"8","volume":"28","author":"F Pagani","year":"2005","unstructured":"Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2005;28(10 Suppl):8\u201313.","journal-title":"J Endocrinol Invest"},{"key":"6661_CR35","doi-asserted-by":"publisher","first-page":"110011","DOI":"10.1016\/j.intimp.2023.110011","volume":"118","author":"F Yu","year":"2023","unstructured":"Yu F, Chang J, Li J, et al. Protective effects of Oridonin against osteoporosis by regulating immunity and activating the Wnt3a\/beta-catenin\/VEGF pathway in ovariectomized mice. Int Immunopharmacol. 2023;118:110011.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"6661_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1445-5994.1991.tb00457.x","volume":"21","author":"BE Nordin","year":"1991","unstructured":"Nordin BE, Need AG, Horowitz M, et al. Osteoporosis and calcium. Aust N Z J Med. 1991;21(2):275\u20139.","journal-title":"Aust N Z J Med"},{"key":"6661_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41232-018-0078-5","volume":"38","author":"S Sumitomo","year":"2018","unstructured":"Sumitomo S, Nagafuchi Y, Tsuchida Y, et al. Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review. Inflamm Regen. 2018;38:21.","journal-title":"Inflamm Regen"},{"issue":"1","key":"6661_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13018-019-1210-1","volume":"14","author":"J Bai","year":"2019","unstructured":"Bai J, Xu Y, Dieo Y, et al. Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats. J Orthop Surg Res. 2019;14(1):177.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"6661_CR39","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00039.2011","volume":"301","author":"KJ Rowland","year":"2011","unstructured":"Rowland KJ, Brubaker PL. The cryptic mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol. 2011;301(1):G1\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"6661_CR40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/gast.2000.16489","volume":"119","author":"B Yusta","year":"2000","unstructured":"Yusta B, Huang L, Munroe D, et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology. 2000;119(3):744\u201355.","journal-title":"Gastroenterology"},{"key":"6661_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6793-11-12","volume":"11","author":"EL Pacheco-Pantoja","year":"2011","unstructured":"Pacheco-Pantoja EL, Ranganath LR, Gallagher JA, et al. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol. 2011;11:12.","journal-title":"BMC Physiol"},{"issue":"6","key":"6661_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/jbmr.5650090610","volume":"9","author":"RT Franceschi","year":"1994","unstructured":"Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res. 1994;9(6):843\u201354.","journal-title":"J Bone Min Res"},{"issue":"7","key":"6661_CR43","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0165-6147(03)00163-9","volume":"24","author":"MP Wymann","year":"2003","unstructured":"Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling\u2013which way to target? Trends Pharmacol Sci. 2003;24(7):366\u201376.","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"6661_CR44","doi-asserted-by":"publisher","first-page":"e104154","DOI":"10.1371\/journal.pone.0104154","volume":"9","author":"Z Xiao","year":"2014","unstructured":"Xiao Z, Huang J, Cao L, et al. Osteocyte-specific deletion of Fgfr1 suppresses FGF23. PLoS ONE. 2014;9(8):e104154.","journal-title":"PLoS ONE"},{"issue":"5","key":"6661_CR45","first-page":"1045","volume":"35","author":"VK Srivastava","year":"2009","unstructured":"Srivastava VK, Yasruel Z, Nalbantoglu J. Impaired medulloblastoma cell survival following activation of the FOXO1 transcription factor. Int J Oncol. 2009;35(5):1045\u201351.","journal-title":"Int J Oncol"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-026-06661-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:03:38Z","timestamp":1770285818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-026-06661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6661"],"URL":"https:\/\/doi.org\/10.1186\/s13018-026-06661-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments conformed to the Guide for the Care and Use of Laboratory Animals. Animal study has been approved by the Animal Ethics Committee of Zhongshan Hospital. All methods are reported in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}